Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Macrabin Injection
- Development stage
- Unknown
- Lead developer
- TCF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous
01
Overview
Macrabin Injection is a multi-vitamin nutritional supplement developed and marketed by TCF Pharmaceuticals. It is formulated as an injectable solution containing a combination of essential B-complex vitamins: Vitamin B1 (thiamine), Vitamin B6 (pyridoxine), Vitamin B12 (cyanocobalamin), Vitamin B2 (riboflavin), Niacinamide, and D-panthenol (dexpanthenol). The injection is indicated for the treatment and prevention of nutritional deficiencies, particularly B-vitamin deficiencies, supporting cellular metabolism, nerve function, and overall physiological health.
- Brand names
- MacrabinMacrabin Injection
- Other names
- Vitamin B1 + Vitamin B6 + Vitamin B12 + Vitamin B2 + Niacinamide + D-panthenolthiamine + pyridoxine + cyanocobalamin + riboflavin + niacinamide + dexpanthenolthiamine + pyridoxine + cyanocobalamin + riboflavin + niacinamide + panthenolthiamine + pyridoxine + cyanocobalamin + riboflavin + nicotinamide + dexpanthenolthiamine + pyridoxine + cyanocobalamin + riboflavin + nicotinamide + panthenol
02
Targets
MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)PARP1 (Poly (adp-ribose) polymerase 1)PANK (Pantothenate kinase)PDXK (Pyridoxal kinase)RFK (Riboflavin kinase)TPK1 (Thiamine pyrophosphokinase 1)
Beyond the preview
Go deeper on Macrabin Injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Macrabin Injection.